Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CRI | Common Stock | Options Exercise | $267K | +4.5K | +5.61% | $59.27 | 84.8K | Dec 2, 2022 | Direct | F1, F2 |
transaction | CRI | Common Stock | Sale | -$327K | -4.5K | -5.31% | $72.59 | 80.3K | Dec 2, 2022 | Direct | F1, F2, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CRI | Employee Stock Option (Right to Purchase) | Options Exercise | $0 | -4.5K | -100% | $0.00* | 0 | Dec 2, 2022 | Common Stock | 4.5K | $59.27 | Direct | F4 |
Id | Content |
---|---|
F1 | The transaction reported in this Form 4 was effectuated pursuant to a Rule 10b5-1 trading plan. |
F2 | Some of these shares are restricted shares that are subject to either time-vesting or performance-based restrictions. |
F3 | This is a weighted average price. The shares were sold in multiple trade executions at prices ranging from $72.00 to $73.19, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. |
F4 | The option vested in four equal installments on February 20, 2014, 2015, 2016, and 2017. |